retatrutide investigational drug review VisualAbstract: reduces body weight by 17.5% in patients with obesity Who Makes Retatrutide? Company Behind

Glucagon-like peptide-1 receptor agonists and muscle strength changes in older adults: Risks beyond muscle mass reductions

Patients who remain consistent with medication use and follow medical guidance often see more stable progress

Gradual dose titration of GLP-1 medications, as per manufacturer recommendations, helps minimise gastrointestinal side effects

The bottom line: GLP-1s have many health benefits, and while there is some evidence to support an association between them and serious eye conditions, that link should not be overstated, and must be considered within the greater context of your individual health

These are general guidelines which may not be suitable for everyone